Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan
暂无分享,去创建一个
B E Butterworth | T. Goldsworthy | J. Popp | B. Butterworth | J A Popp | D M Wilson | T L Goldsworthy | D. Wilson | B. E. Butterworth
[1] J. Yager,et al. Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. , 1986, Carcinogenesis.
[2] L. Ellwein,et al. Cell proliferation in carcinogenesis. , 1990, Science.
[3] B. Butterworth,et al. Nongenotoxic carcinogens in the regulatory environment. , 1989, Regulatory toxicology and pharmacology : RTP.
[4] J. Yager,et al. Lack of hepatogenotoxicity of oral contraceptive steroids. , 1982, Carcinogenesis.
[5] R. Cattley,et al. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.
[6] J. Miller,et al. Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats. , 1988, Carcinogenesis.
[7] M. Boyd,et al. Metabolic activation of 2-methylfuran by rat microsomal systems. , 1985, Toxicology and applied pharmacology.
[8] J. Swenberg,et al. Elevated proliferation of proximal tubule cells and localization of accumulated alpha 2u-globulin in F344 rats during chronic exposure to unleaded gasoline or 2,2,4-trimethylpentane. , 1989, Toxicology and applied pharmacology.
[9] M. Boyd,et al. Reactive metabolites from the bioactivation of toxic methylfurans. , 1984, Science.
[10] A. Columbano,et al. Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis. , 1987, Carcinogenesis.
[11] J. Ashby,et al. A protocol and guide for the in vitro rat hepatocyte DNA-repair assay. , 1987, Mutation research.
[12] G. Traiger,et al. Toxicity-distribution relationships among 3-alkylfurans in mouse liver and kidney. , 1984, Toxicology and Applied Pharmacology.
[13] H. Bergmeyer,et al. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. , 1978, Clinical chemistry.
[14] J. Miller,et al. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Egle,et al. Respiratory retention and acute toxicity of furan. , 1979, American Industrial Hygiene Association journal.
[16] M. Armstrong,et al. Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double-strand breaks. , 1987, Mutation research.
[17] F. Guengerich. Studies on the activation of a model furan compound--toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl)furan. , 1977, Biochemical pharmacology.
[18] M E Andersen,et al. Development of a physiologically based pharmacokinetic model for chloroform. , 1990, Toxicology and applied pharmacology.
[19] J. Mitchell,et al. Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. , 1977, Toxicology and applied pharmacology.
[20] B. Butterworth,et al. Role of gut flora in the genotoxicity of dinitrotoluene , 1982, Nature.
[21] A. Columbano,et al. Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. , 1989, Carcinogenesis.
[22] R J Albertini,et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.
[23] J. Swenberg,et al. Promoting effects of unleaded gasoline and 2,2,4-trimethylpentane on the development of atypical cell foci and renal tubular cell tumors in rats exposed to N-ethyl-N-hydroxyethylnitrosamine. , 1989, Cancer research.
[24] B H Margolin,et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. , 1987, Science.
[25] B. Butterworth,et al. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. , 1990, Mutation research.
[26] M. Guerin,et al. Routine gas chromatographic component profiling of cigarette smoke for the identification of biologically significant constituents. , 1974, Journal of Chromatographic Science.
[27] A. Columbano,et al. Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. , 1987, Cancer research.
[28] W. Powrie,et al. Clastogenicity of furans found in food. , 1981, Cancer letters.
[29] E. Zeiger,et al. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.
[30] P. Capurro,et al. Effects of exposure to solvents caused by air pollution with special reference to CCl 4 and its distribution in air. , 1973, Clinical toxicology.
[31] J. Swenberg,et al. Differential repair of O4-alkylthymidine following exposure to methylating and ethylating hepatocarcinogens. , 1985, Carcinogenesis.
[32] A. Yamaguchi,et al. The effects of diethyldithiocarbamate and carbon disulfide on acute nephrotoxicity induced by furan, bromobenzene and cephaloridine in mice. , 1984, Japanese journal of pharmacology.
[33] T. Fox,et al. Detection of a cellular oncogene in spontaneous liver tumors of B6C3F1 mice. , 1985, Science.
[34] T. Fox,et al. Activation of a cellular proto-oncogene in spontaneous liver tumor tissue of the B6C3F1 mouse. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[35] D. Lovell. Nongenotoxic mechanisms in carcinogenesis: Banbury Report 25: Edited by B. E. Butterworth & T. J. Slaga. Cold Spring Harbor Laboratory, New York, 1987. pp. xv + 397. $70.00. ISBN 0-87969-225-1 , 1988 .
[36] J. Swenberg,et al. Histopathology and Cell Proliferation Induced by 2,2,4-Trimethylpentane in the Male Rat Kidney , 1986, Toxicologic pathology.
[37] Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a]anthracene. , 1990, Toxicology and applied pharmacology.
[38] R. Maronpot,et al. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[39] R R Maronpot,et al. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. , 1987, Science.
[40] J. Swenberg,et al. Biochemical Mechanisms and Pathobiology of α2u-Globulin Nephropathy , 1990 .
[41] R. Cattley,et al. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. , 1989, Cancer research.
[42] J. Yager,et al. Effects of the liver tumor promoter ethinyl estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. , 1989, Cancer research.
[43] D. Beer,et al. Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent liver. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[44] R. Irwin,et al. Disposition of [14C]furan in the male F344 rat. , 1991, Journal of toxicology and environmental health.
[45] D. Mcgregor,et al. Responses of the L5178Y tk+/tk− mouse lymphoma cell forward mutation assay ii: 18 coded chemicals , 1988, Environmental and molecular mutagenesis.
[46] S. Sell,et al. Is there a liver stem cell? , 1990, Cancer research.